Jump Financial, LLC Charles River Laboratories International, Inc. Transaction History

Jump Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $774,019 - $1.01 Million	-4,118 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $629,902 - $820,163	3,052 Added 286.3%	4,118 $850,000
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $216,952 - $291,476	1,066 New	1,066 $288,000
Q3 2023 Oct 21, 2024	SELL	$194.44 - $217.61 $162,162 - $181,486	-834 Reduced 44.67%	1,033 $202,000
Q3 2023 Nov 07, 2023	SELL	$194.44 - $217.61 $162,162 - $181,486	-834 Reduced 44.67%	1,033 $202,000
Q2 2023 Oct 21, 2024	BUY	$183.71 - $210.25 $119,962 - $137,293	653 Added 53.79%	1,867 $392,000
Q2 2023 Aug 07, 2023	BUY	$183.71 - $210.25 $119,962 - $137,293	653 Added 53.79%	1,867 $392,000
Q1 2023 Oct 21, 2024	SELL	$191.89 - $259.92 $557,248 - $754,807	-2,904 Reduced 70.52%	1,214 $245,000
Q1 2023 May 03, 2023	BUY	$191.89 - $259.92 $232,954 - $315,542	1,214 New	1,214 $245,000
Q3 2022 Nov 07, 2022	BUY	$182.44 - $250.54 $1.25 Million - $1.72 Million	6,865 New	6,865 $1.35 Million
Q2 2022 Aug 09, 2022	SELL	$204.13 - $302.4 $1.43 Million - $2.12 Million	-7,004 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $1.79 Million - $2.54 Million	7,004 New	7,004 $1.99 Million

693

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.